Kavita V Dharmarajan, MD

Kavita Dharmarajan, MD, MSc, is a board-certified radiation oncologist and Associate Professor of Radiation Oncology, Geriatrics, and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. She also serves as Director of the Quality and Performance Improvement Committee in the Department of Radiation Oncology at Mount Sinai Hospital. Dr. Dharmarajan’s clinical work is focused on providing radiation treatment for metastatic cancers and multiple myeloma using a multidisciplinary, patient-centered approach. She has specialized expertise in advanced radiation techniques including stereotactic radiotherapy and hypofractionation, and she has worked extensively with vulnerable patient populations including those with multiply relapsed/refractory multiple myeloma, oligometastatic disease, and older adults. At Mount Sinai, she developed one of the first care delivery models in the nation to provide specialized multidisciplinary care for persons diagnosed with advanced or incurable cancers.

In addition to her clinical practice, Dr. Dharmarajan is an NIH-funded clinician-investigator and currently the principal investigator on a clinical study evaluating the trajectories of functional status over time among older adults who undergo radiation therapy as part of their cancer treatment. She has been co-principal investigator on numerous clinical studies combining radiation therapy and phase I-II anti-cancer agents including those that include the use of immunomodulatory drugs and biospecific agents in multiple myeloma and other cancers. Her work has been supported by the National Institute on Aging, the National Palliative Care Research Center, and the American Medical Association Foundation.

Dr. Dharmarajan has published over 60 original research articles, textbook chapters, and invited papers, and she has served on several national and international committees to promote the education and uptake of radiation therapy for treatment of metastatic disease and multiple myeloma. In recognition of her clinical excellence and innovation in research, she has been the recipient of the Association of Community Cancer Center’s Innovator Award and the American Geriatrics Society’s Silverstein Memorial Award.